Hollings Clinical Trials
Free
1.0.4for iPhone, iPad and more
9.9
1 Ratings
The Medical University of South Carolina
Developer
501.8 KB
Size
Sep 28, 2023
Update Date
Medical
Category
12+
Age Rating
Age Rating
Hollings Clinical Trials Screenshots
About Hollings Clinical Trials
This application is designed for health professionals seeking clinical trial opportunities for cancer treatments opened at the Medical University of South Carolina (MUSC) Hollings Cancer Center (HCC) or at any cancer center within the MUSC NCI Community Oncology Research Program for Minority and Underserved (NCORP-MU). Clinical trials are research studies looking at novel therapies that are considered investigational.
This application is organized by the following cancer disease groups: Brain, Breast, Gastrointestinal (colorectal, pancreas, liver, etc.), Genitourinary (prostate, bladder, kidney, etc.), Gynecologic (ovarian, cervical, uterine etc.), Head and Neck, Hematologic (leukemia, lymphoma, myeloma), Lung, Melanoma, Pediatric (all disease sites accruing children), and Sarcoma. Early phase clinical trials that enroll across many cancer types are organized under the “Phase I Unit.”
Users must select the disease group and click through specific patient characteristics or treatment options to narrow down the trial opportunities that are actively enrolling patients at MUSC HCC. Trial opportunity links open a study-specific webpage that contains summary trial information such as study objectives and study contacts. MUSC employees who have a MUSC Net ID can access study documents like protocol and informed consents. Users may click on the NCT link to connect to the CT.gov webpage and find the current trial eligibility criteria. All users can submit a contact request for help, and an employee of the Hollings Cancer Center Clinical Trials Office will respond.
This application is organized by the following cancer disease groups: Brain, Breast, Gastrointestinal (colorectal, pancreas, liver, etc.), Genitourinary (prostate, bladder, kidney, etc.), Gynecologic (ovarian, cervical, uterine etc.), Head and Neck, Hematologic (leukemia, lymphoma, myeloma), Lung, Melanoma, Pediatric (all disease sites accruing children), and Sarcoma. Early phase clinical trials that enroll across many cancer types are organized under the “Phase I Unit.”
Users must select the disease group and click through specific patient characteristics or treatment options to narrow down the trial opportunities that are actively enrolling patients at MUSC HCC. Trial opportunity links open a study-specific webpage that contains summary trial information such as study objectives and study contacts. MUSC employees who have a MUSC Net ID can access study documents like protocol and informed consents. Users may click on the NCT link to connect to the CT.gov webpage and find the current trial eligibility criteria. All users can submit a contact request for help, and an employee of the Hollings Cancer Center Clinical Trials Office will respond.
Show More
What's New in the Latest Version 1.0.4
Last updated on Sep 28, 2023
Old Versions
-updated navigation bar
Show More
Version History
1.0.4
Sep 28, 2023
-updated navigation bar
1.0.3
Aug 29, 2023
-updated navigation bar
1.0.2
Aug 24, 2023
New logo and updated layout
1.0.1
May 12, 2022
-updated app store listing name
1.0
May 9, 2022
Hollings Clinical Trials FAQ
Click here to learn how to download Hollings Clinical Trials in restricted country or region.
Check the following list to see the minimum requirements of Hollings Clinical Trials.
iPhone
Requires iOS 14.5 or later.
iPad
Requires iPadOS 14.5 or later.
iPod touch
Requires iOS 14.5 or later.
Hollings Clinical Trials supports English